Alternate Text Alternate Text Alternate Text

Supported by:Department of Scientific and Industrial Research (DSIR), Government of India, and the Council of Scientific and Industrial Research (CSIR).

Home
Pilot/R&D to Phase II Clinical Trial Batches (including placebos) under Form 29 License or Form CT-11 Permission. Across the board: from conventional oral and topical formulations to transdermal systems, pulmonary drug delivery, liposomes, nanoparticles…(Sterile products in next phase).

The facility offers

  • Design, development and manufacture of new formulations.

  • Optimize, validate and scale-up Processes.

  • Develop and validate In-Process Quality Check (IPQC) protocols.

  • GMP R&D scale enables cost saving.